Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EONS Rapid-fire session 1

CN88 - The effectiveness of virtual reality use in cancer patients: A systematic review

Date

14 Sep 2024

Session

EONS Rapid-fire session 1

Topics

Supportive Care and Symptom Management

Tumour Site

Presenters

Tugce Ucgun

Citation

Annals of Oncology (2024) 35 (suppl_2): S1197-S1204. 10.1016/annonc/annonc1586

Authors

E. AKGÜN ÇITAK, T. Ucgun

Author affiliations

  • Psychiatric Nursing, Baskent University, 06790 - Ankara/TR

Resources

This content is available to ESMO members and event participants.

Abstract CN88

Background

With the advancement of technology, the use of virtual reality (VR) in institutions such as hospitals is increasing considerably. VR, increasingly being explored as a cost-effective digital therapeutic, is a technology that simulates a natural environment. This potential of VR to create a profound sense of presence is particularly promising for its use in managing anxiety and depression and reducing pain in cancer patients. However, the feasibility and impact of VR in this context still need to be explored. Therefore, this systematic review study aimed to reveal the effectiveness of VR therapy in cancer patients.

Methods

In this study, between 2019 and 2024, randomized controlled (RC) studies were searched through PubMed (MEDLINE), EBSCO, and SCOPUS. MeSH (Medical Subjects Headings) were searched for keywords and Boolean connectors were used to search for the keywords "virtual reality" AND (“cancer” OR “cancer patients”). We meticulously included only RCT and studies written in English. Two independent researchers diligently reviewed the studies and identified articles that met the strict inclusion criteria. The PRISMA guide, a gold standard for reporting systematic reviews, ensured the highest transparency and reliability in reporting the study.

Results

637 articles were identified. After eliminating studies with repetitive and inappropriate subject titles, content, methods, or samples, 26 studies met the inclusion criteria. Among these, 10 studies focused on pediatric cancer patients, while 16 focused on adults. VR has significant physiological and psychological benefits in improving the well-being of cancer patients. When the studies are examined, it found that VR is effective on pain (n:14), anxiety (n:10), mood changes (n:5), fear (n:5), psychological well-being (n:4), depression (n:3), quality of life (n:2), self-efficacy (n:2) and other symptoms (such as fatigue, nausea, quality of sleep).

Conclusions

As a result of our findings underscore VR's effectiveness in alleviating pain, reducing anxiety, improving mood changes, reducing fear, and enhancing overall psychological well-being among the cancer population. These results highlight VR emphasizing its potential to alleviate symptoms and enhance the quality of life in this population.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.